Consolidated Statement of Activities
Year ended September 30, 2020
Revenues | |
---|---|
Contributions |
$ 744,587 |
Grants and contracts |
485,364,457 |
Investment income |
2,018,893 |
Licensing fees and other |
4,050,344 |
Net assets released from restrictions and transfers |
- |
Total revenues |
492,178,281 |
Expenses |
|
Program services |
|
Research grants and contracts |
469,954,200 |
Other program activities |
11,841,237 |
Endowment and similar programs |
2,574,521 |
Education projects |
1,575,131 |
Total program services |
485,945,089 |
Total support services |
5,375,374 |
Total expenses |
491,320,463 |
Change in net assets |
857,818 |
Net Assets, beginning of year |
139,884,177 |
Cumulative effect of a change in accounting principle related to revenue recognition |
2,287,810 |
Net Assets, end of year |
143,029,805 |
Consolidated Statement of Financial Position
September 30, 2020
Assets |
|
---|---|
Cash and cash equivalents |
$ 62,533,823 |
Grants and contracts receivable, net |
114,068,472 |
Prepaid expenses and other current assets |
7,267,283 |
Investments |
52,872,221 |
Property and equipment, net |
11,086,387 |
Other Assets |
4,974,894 |
Total Assets |
$ 252,803,080 |
Liabilities and Net Assets |
|
Accounts payable and accrued expenses |
$58,003,422 |
Accrued leave and benefits |
20,989,116 |
Deferred revenue |
14,049,291 |
Deferred rent |
7,280,785 |
Other payables |
9,450,661 |
Total Liabilities |
109,773,275 |
Net assets |
|
Without donor restriction |
95,937,359 |
With donor restriction |
47,092,446 |
Total net assets |
143,029,805 |
Total liabilities & net assets |
$ 252,803,080 |